Clinical Trial Update: Calcium Channel Blockade in Primary Aldosteronism [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating calcium channel blockade for primary aldosteronism has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aldosteronism

Drugs mentioned

• Calcium channel blocker (investigational)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Primary Aldosteronism, Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral) | Phase 2 | Status: COMPLETED | Results posted: 2025-04-15